From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values
Eur Heart J
.
2017 Nov 21;38(44):3258-3271.
doi: 10.1093/eurheartj/ehx643.
Authors
Thomas F Lüscher
1
,
Sverre E Kjeldsen
2
,
Giuseppe Mancia
3
,
Vasilios Papademetriou
4
Affiliations
1
Royal Brompton and Harefield Hospital Trust and Imperial College, London, UK.
2
The Department of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway
3
IRCCS Istituto Auxologico Italiano, University of Milano-Bicocca, Milan, Italy
4
Department of Cardiology, VA Medical Center and Georgetown University, 50 Irving Str. NW, Washington, DC 20422, USA
PMID:
29177419
DOI:
10.1093/eurheartj/ehx643
No abstract available
Publication types
Review
MeSH terms
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects*
Essential Hypertension / drug therapy*
Essential Hypertension / physiopathology
Humans
Substances
Antihypertensive Agents